Erin Trachet

Assists TD2’s commercial sales team in generating rigorous preclinical study proposals by advancing the scientific discussions.

· Works closely with nonclinical team members to gain insight into current offerings that will support R&D planning efforts and TD2 sponsor needs.

· Works closely with the nonclinical leadership team, scientific product marketing, and the commercial sales team to identify new service offerings and assist with the development and roll-out of a go-to-market strategy.

· Liaises with marketing and assists with translating the current and new offerings into public facing documents that articulate the scientific offering.

· Develops innovative scientific approaches and strategies with the intent to identify new business opportunities and offerings with the company’s current and prospective client base.

· Supports business operations team with preclinical study design and development of proposals and study protocols.

· Works with the nonclinical team and marketing to design studies and generate content for the purpose of abstract and poster submission at industry conferences, scientific presentations, webinars, and symposia. May also include representation of the company at these events.

· Recognizes scientific sales barriers and develops methods with the commercial sales team and marketing to overcome them.

· Works as a member of the company’s senior leadership team to lead the identification and business/scientific diligence on enabling partnerships, acquisition targets, and identification and acquisition of new technologies and model systems that can be deployed as service offerings.

· Monitors and reports M&A competitor activities, landscape trends and key marketplace activities.

· Moderate travel may be required to attend sponsor meetings as well as conferences and symposia.

· Performs other duties as assigned.

• Fostered work culture of collaboration and inclusion to increase morale and reduce turnover.
• Created an agile working environment, enabling rapid response to changing business needs without sacrificing quality or performance standards.
• Managed risk effectively by identifying potential threats, developing contingency plans, and implementing mitigation strategies in line with overall business objectives.
• Achieved departmental goals by developing and implementing strategic plans and initiatives.
• Established data-driven decision-making processes and implemented best practices in analytics to optimize performance across the organization.
• Optimized project timelines by effectively delegating tasks and prioritizing workload among team members.
• Cultivated a culture of innovation by promoting creative thinking and encouraging employees to take calculated risks in pursuit of solutions.
• Developed strong relationships with key industry partners, fostering collaboration and mutual growth opportunities.

· Utilized expertise in preclinical oncology to drive direct and independent scientific engagement with pharmaceutical company scientists, clients, and decision makers with the goal of providing high level scientific input in program goal setting, study design, risk mitigation and model execution to determine how, and when their discovery and translational programs would benefit from PCO services.

· Supported the Business Development Directors goals to secure orders and deepen account penetration through increasing the quality and quantity of meetings with pharmaceutical company scientist; ensured the best possible exchange of information for new opportunities between BDD and the scientific team; ensured successful protocol generation, scientifically justified and execution ready study designs and proposals to define projects/studies and associated prices.

o Assumed primary responsibility, for direct interactions with certain accounts for purposes of deepening relationships and provision of services, with associated follow up communications to the appropriate BDD representation.

· Worked autonomously in the use of the site bidding and protocol designing tool. All protocols/quotes will accurately capture all cost and execution details accurately.

· Managed 4 (at most) Sci Dev direct reports. Provided guidance to allow them to develop a working knowledge of the preclinical oncology models that PCO offers; this included in vivo, in vitro and imaging services. Provided opportunity for clients facing growth via client engagement shadowing and protocol design collaboration.

o Compiled and translated protocol information to Junior Sci Dev staff to allow pricing and proposal generation in the bid tool system. Collaborated with Jr staff to ensure that the protocol is execution ready and has been costed accurately (i.e., formal statement of work (SOW)). Once completed, the finalized protocol and project price to the appropriate Business Development Director (BDD) for delivery to the client.

· Drove and developed independent teams across the whole PCO site to address greater service and business needs. These opportunities focused on the growth of PCO services and business model improvements. Sci Dev and PCO leadership approved, and members will be assigned from other teams within the whole PCO group. The incumbent will be the primary point of contact for the project and directly responsible for the assessment of ROI and will make a business and scientific justification for the project. The incumbent will have direct responsibility for the successful completion, providing timely updates and development and distribution of collateral.

· Supported the continued development of scientific and/or technical marketing materials for commercial use, which takes the form of white papers, data sets, presentations, or website content.

· Maintained general currency in scientific areas in which the Preclinical Oncology site is engaged and in which the incumbent may be a subject matter expert.

• Led teams of up to 6 personnel, supervising daily performance as well as training and improvement plans.
• Prioritized tasks and allocated resources appropriately to keep teams focused and productive.
• Assisted senior leadership in managing all aspects of operations.
• Fostered a culture of continuous improvement by encouraging staff to share innovative ideas and providing resources for professional development.
• Trained and developed department leaders and management staff for specific projects and ongoing operational needs.
• Mentored junior staff members, providing guidance on professional development opportunities and career progression paths within the company.
• Managed cross-functional teams for multiple large-scale projects, successfully completing each on time and within budget constraints.
• Established strong relationships with key industry partners, creating mutually beneficial opportunities for growth and collaboration.
• Improved overall team efficiency by streamlining project management processes and implementing new collaboration tools.
• Implemented data-driven decision-making strategies, leading to more informed business choices and positive outcomes.
• Leveraged data and analytics to make informed decisions and drive business improvements.

· Directed scientific engagement with pharmaceutical company scientists, clients, and decision makers with the goal of providing high level scientific input in study design and model execution to determine how, and when their discovery and translational programs would benefit from Molecular Imaging’s preclinical oncology services.

· Supported the Companies Business Development (BD) goals to secure orders and deepen account penetration through increasing the quality and quantity of meetings with pharmaceutical company scientist; ensured the best possible exchange of information for new opportunities between BD and the scientific team; generated protocols, study designs and proposals to define projects/studies and associated prices.

· Periodically co-travelled with BD (~25% of the time) to various clients and potential clients to support scientific discussion of Companies services and capabilities.

· Represented MII at relevant scientific and industry conferences, including preparation of oral presentations and/or poster presentations; and

Supported the continued development of company-based scientific marketing collateral and web

• Maintained up-to-date knowledge on industry trends and regulations, ensuring accurate advice was provided to clients at all times.
• Developed long-lasting relationships with clients to ensure consistent retention and loyalty.
• Managed risk effectively by closely monitoring client portfolios and making timely adjustments.
• Utilized advanced CRM tools to track client interactions efficiently while maintaining detailed records of their individual goals, preferences, and concerns.
• Mentored junior advisors, fostering a supportive team environment focused on growth and learning.
• Developed strong relationships with clients through regular communication and excellent customer service.
• Participated in ongoing professional development opportunities to stay current with industry trends and best practices.
• Collaborated with cross-functional teams to launch series of successful financial education seminars.
• Spearheaded sustainability initiative within investment portfolios, aligning client values with their financial goals.
• Optimized operational efficiency by implementing CRM system tailored to advisory services.
• Enhanced team productivity with introduction of streamlined processes for client assessments and follow-ups.
• Pioneered client onboarding process that significantly reduced time to first investment.
• Boosted client portfolio performance, selecting and managing diverse range of investment vehicles.
• Developed comprehensive risk assessment tool, enabling more precise investment recommendations.
• Strengthened client relationships through regular, insightful communication regarding market trends and portfolio adjustments.
• Facilitated workshops on financial planning for high-net-worth individuals, improving their understanding of wealth management.
• Cultivated network of industry professionals to support client needs beyond traditional financial advisory services.
• Streamlined client reporting mechanisms, providing more transparent and accessible investment performance data.

• In July 2010, Charles River, Discovery, and Imaging Services was purchased by Molecular Imaging, Inc. As part of the senior leadership team, I was directly involved in the integration and implantation of new corporate procedures and policies. Key responsibilities were similar between the two roles and are described in detail above.
• Provided strong leadership to enhance team productivity and morale.
• Led cross-functional teams to achieve project milestones and deliver high-quality results.
• Established strong relationships with clients and stakeholders, ensuring long-term partnerships and repeat business.
• Improved team performance by providing comprehensive training and fostering a collaborative work environment.

· Directed the cancer pharmacology business unit generating over $3M in annual revenue (2010) and managed vivarium for all therapeutic areas. Key member of the Senior Management Team reporting to the site General Manager.

· As the Senior Manager of the Pharmacology section, I was responsible for the management of the scientific and business growth and performance of the group.

· The function of the Senior Management Team was to set and approve the business strategic direction. As a member I provided guidance on all site issues, including strategic growth of the business, business development/marketing, HR policy, capital and physical plant expenditures, and finance.

· Managed the vivarium and associated animal care group.

In September 2008, Molecular Imaging Research (MIR) was purchased by Charles River Laboratories. As part of the senior management team, I was directly involved in the integration and implantation of new corporate procedures and policies.

• Provided strong leadership to enhance team productivity and morale.
• Led cross-functional teams to achieve project milestones and deliver high-quality results.
• Established strong relationships with clients and stakeholders, ensuring long-term partnerships and repeat business.
• Improved team performance by providing comprehensive training and fostering a collaborative work environment.

· Supervised and executed in vivo experiments. Coordinated all technical aspects of client studies. Collected and analyzed data and prepared final written reports.

o Expert in rodent handling and dosing (mouse and rats) via multiple routes such as IP, PO, IV, IM, IC, IT and intra-dermal.

o Proficient in rodent micro survival surgeries for tumor cell implants and tumor resections. As well as blood collection procedures, such as retro orbital, submandibular and terminal cardiac puncture.

· Maintained in vivo tumor passage for 10-15 core xenograft tumor lines.

· Primary point of service for assigned clients. Provided interim reports to clients and managed experimental timelines. Handled all special requests, questions, or protocol changes. Consulted with clients on experimental design. Participated in study cost analysis and bid preparation.

· Participated in and/or led the creation and validation of new models, technologies, or services for MIR.

· Participated in laboratory management and assisted others with their in vivo workload.

• Provided strong leadership to enhance team productivity and morale.
• Led cross-functional teams to achieve project milestones and deliver high-quality results.